Skip to content
Review Open access

On the road to fully automated insulin delivery: A systematic review of meal announcement free algorithms

Jul 2026 · PLOS Digital Health · Vol 5, pp. e0001492 · 0 citations · 95 references
Medicine

TL;DR

Automated meal detection and compensation algorithms show promise for integration into FAID systems, with encouraging detection performance and glycemic outcomes, but the evidence remains heterogeneous, and a substantial portion is still based on in-silico studies rather than clinical validation.

Abstract

Fully automated insulin delivery (FAID) systems aim to regulate blood glucose levels in individuals with type 1 diabetes with minimal user input. A key challenge to achieving full automation is the need for manual meal announcements. This review focuses on algorithms developed to detect and compensate for unannounced meals. A systematic literature search was conducted across PubMed, Scopus, IEEE Xplore, and Web of Science (2000 – 2025), and the review was reported in accordance with PRISMA guidelines. From 1205 initially retrieved articles, 69 studies met predefined eligibility criteria and were included in the final review. Extracted data included algorithm type, data source (in-silico or clinical), performance metrics, and glycemic outcomes where available. The reviewed algorithms include heuristic rule-based methods, machine learning models, and control systems theory approaches. While varying in complexity and detection strategies, these approaches aim to identify meal events and estimate carbohydrate intake for timely insulin dosing. Median performance across studies included a sensitivity of 88%, precision of 93%, and detection times ranging from 25 to 40 minutes. In-silico evaluations generally reported more false positives than in-vivo. Reported glycemic outcomes demonstrated time-in-range values between 65% and 89%, highlighting the potential of these systems to support fully autonomous glucose regulation. Automated meal detection and compensation algorithms show promise for integration into FAID systems, with encouraging detection performance and glycemic outcomes. However, the evidence remains heterogeneous, and a substantial portion is still based on in-silico studies rather than clinical validation. Challenges remain in minimizing false positives, ensuring generalizability across populations, and validating performance in real-word settings.

Read PDF

Similar papers

Review Open access Jul 2026

From algorithm to alarm: a narrative review on insulin delivery innovation

Close-loop insulin delivery systems seem to be a more clinically successful option for controlling diabetes mellitus than SAP therapy, and sensor-augmented and closed-loop systems offer better glucose control and lower hypoglycemia rates compared to traditional therapies.

Noor ul ain Saleem, Faraz Arshad, M. Qadri et al. · 0 citations
Review Aug 2026

Kontinuierliche Glukosemessung und automatisierte Insulindosierungssysteme im klinischen Alltag

A practice-oriented evaluation of the indications, clinical benefits, and safety of modern diabetes technologies and suggests that technologies should be offered according to individual needs, abilities, preferences, and life circumstances and implemented early, including at the time of diagnosis.

A. Mathew, D. Führer · 0 citations
Open access Jul 2026

Simplifying meal bolusing with Omnipod 5: real-world outcomes to support simplified user-initiated insulin dosing strategies in managing type 1 or type 2 diabetes.

Glycemic outcomes with simplified bolusing were non-inferior to carbohydrate counting, suggesting carbohydrate counting ability should not affect AID access.

Georgia M. Davis, Gregory P. Forlenza, B. Gehr et al. · 0 citations
Review Aug 2026

Early Consideration of Automated Insulin Delivery in Type 2 Diabetes: A Critical Review.

Randomized and real-world studies demonstrate that AID systems significantly improve A1C and time in range while minimizing hypoglycemia, without increasing treatment complexity or patient burden, and position AID as a practical and effective strategy to overcome long-standing therapeutic inertia in type 2 diabetes.

Z. Tariq, Grazia Aleppo, Anders L. Carlson et al. · 0 citations
Review Open access Jul 2026

Reinforcement Learning for Automated Insulin Delivery: A Comprehensive Review of Methods, Challenges, and Future Directions

RL-based AID systems represent an important step towards fully autonomous and personalized artificial pancreas solutions and will be dependent on multidisciplinary collaboration between AI researchers, clinicians, and regulators to ensure safety, transparency, and reliability in next generation diabetes management.

Madhav Prasad, Neha Tyagi, K. K. Sarma · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.